Alpha Tau Medical Ltd. (DRTS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

3.07

0.33%

After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States.

Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.

The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd.

Country	IL
IPO Date	Mar 8, 2021
Industry	Biotechnology
Sector	Healthcare
Employees	121
CEO	Uzi Sofer

Contact Details

Address: 5 Kiryat Hamada Street Jerusalem, IL
Website	https://www.alphatau.com

Stock Details

Ticker Symbol	DRTS
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001871321
CUSIP Number	M0740A108
ISIN Number	IL0011839383
Employer ID	00-0000000
SIC Code	3841

Key Executives

Name	Position
Uzi Sofer	Chief Executive Officer & Chairman
Raphi Levy	Chief Financial Officer
Ronen Segal	Chief Technology Officer
Amnon Gat	Chief Operations Officer
Dr. Robert B. Den M.D.	Chief Medical Officer & Member of Scientific Advisory Board
Peter M. Melnyk	Chief Commercial Officer
Prof. Itzhak Kelson	Chief Physics Officer & Member of Scientific Advisory Board
Prof. Yona Keisari	Chief Scientific Officer & Member of Scientific Advisory board
Rebecca Becker	Vice President of legal
Yael Zeiger	Corporate Controller

Latest SEC Filings

Date	Type	Title
Dec 11, 2024	6-K	Filing
Dec 06, 2024	6-K	Filing
Nov 19, 2024	6-K	Filing
Nov 13, 2024	6-K	Filing
Nov 12, 2024	6-K	Filing
Oct 21, 2024	6-K	Filing
Oct 10, 2024	6-K	Filing
Sep 20, 2024	6-K	Filing
Aug 22, 2024	6-K	Filing
Aug 14, 2024	6-K	Filing

View All SEC Filings